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Abstract 
Aim: This study was conducted to evaluate the insulin pen application knowledge and skills of  patients with diabetes. 
Methods: In our descriptive study, 200 patients with diabetes were asked to present the insulin pen injection technique on a 
mannequin and the steps of  the pen injection implementation were noted on the data collection form as correct/incorrect by 
researchers. 
Results: More than 3 out of  4 (79.5%) of  the participants were using the insulin pen or the cartridge after the expiry date, 70.5% 
were not rotating the injection site, and 63.0% were massaging the skin after injection. Injection sites complications were sig-
nificantly more in those who were using the insulin pen or the cartridge after the expiry date, those who don’t know the proper 
length of  the needle and the possible body injection sites, those who don’t rotate the injection sites, those who massage after 
injection, and those who don’t use a new needle at each injection (p<0.05). 
Conclusion: This study put into light some failures in the knowledge and skills of  patients with diabetes regarding insulin pen 
use. Nurses should provide patients with diabetes an effective and repetitive training concerning insulin pen use.
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Diabetes mellitus is one of  the largest global health emer-
gencies of  the 21st century1.  Worldwide, the frequency 
of  diabetes among 20-79 years aged adults was 6.4% (285 
million individuals) in 2010 and it is estimated to be 7.7% 
(439 million individuals) in 2030. In the United States, 
9.3% of  the population (29.1 million individuals) had 
diabetes in 2014 and it is projected to increase by 54% 
between 2015 and 2030. Also, in Turkey the prevalence 
of  diabetes is 13.7% and a significant proportion of  our 
community is candidate for diabetes due to obesity and 
prediabetes2,3. Individuals with diabetes bear a higher risk 
for life-threatening medical problems compared to indi-
viduals without diabetes. Continuous higher glycaemia 
may cause serious disorders affecting heart, blood ves-
sels, eye, kidney and nerves. Moreover, individuals with 
diabetes are at increased risk for infection development. 
Complications of  diabetes can be avoided with controlled 
glycaemia, blood pressure and cholesterol as close to nor-
mal as possible4,5.  In order to keep the complications un-
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der control and the quality of  life satisfactory, patients 
with diabetes should be provided continuous medical and 
nursing care, and training on self-management. The main 
goal of  treatment of  diabetes is achieving a proper gly-
cemic control, thereby minimizing the incidence of  com-
plications5-7.
In maintaining a proper metabolic control, insulin therapy 
has a key role not only for patients with type 1 diabetes, 
but also for patients with type 2 diabetes7.  Ready insulin 
pen is preferred by physicians and patients because of  its 
easiness to use and safeness in dosage regulation8,9.  How-
ever, deficient injection techniques, such as repetitive use 
of  insulin pen needle and not rotating the injection site, 
may hamper a successive glycemic control and requires 
attention10,11. Literature review on patients with diabetes 
show that there are common errors on insulin pen use 
such as, preferring the same anatomical site for injection, 
not implementing the pinch up method correctly, using 
the pen needle multiple times, not performing rotations, 
etc.12,13 If  attention is not devoted, patients may experi-
ence complications such as hypoglycemia, bleeding, ec-
chymosis and lipodystrophy on the injection site. There-
fore, patients should be equipped with knowledge and 
skills to avoid these complications and benefit from the 
treatment13-16. 
There are descriptive studies which assess the attitudes 
of  patients on insulin pen use by enquiries16-19 but the 
studies that use observation of  insulin injection as a tool 
of  assessment in patients who self-administer insulin pen 
are limited19,20. There are no studies assessing the proper 
injection of  insulin with insulin pen, and the effectiveness 
of  patient education by simulation. Given the fact that 
nearly 25% of  medical expenses in Turkey arise from di-
abetes and diabetes related illnesses5, control of  diabetes 
bears a significant importance. Despite the decisive role 
of  proper injection technique in achieving the optimal ef-
fect of  insulin injection, it is rarely an attention payed and 
neglected step14,21. Incorrect injection technique is one 
of  the barriers to intended glycemic control19,22. There-
fore, the supervision of  injection technique during the 
follow-up of  patient by nurse is important to achieve a 
successive insulin treatment. The aim of  this study was to 
evaluate the insulin pen injection knowledge and skills of  
patients with diabetes. 
Methods
Study design and participants
This descriptive study was conducted in the Department 
of  Endocrinology and Metabolism out-patient clinic in a 
training hospital between January and June 2015 in An-
kara, Turkey. 
The eligibility criteria for the patients were: (1) being 18 
years of  age or older; (2) being diagnosed with type 1 
and/or 2 diabetes and not pregnant; (3) being a volun-
teer, and (4) being prescribed 1 or more of  the disposable 
insulin pens for a minimum of  8 weeks. The criterion of  
eight weeks insulin pen use was chosen to observe the 
alteration in HbA1c levels. Red blood cells in the human 
body survive for 8-12 weeks before renewal, HbA1c can 
be used to reflect average blood glucose levels over that 
duration, providing a useful longer-term gauge of  blood 
glucose control5.
During the data collection period, 232 patients with di-
abetes visited the out-patient clinic in 6 months. 32  pa-
tients were excluded due to not being able to volunteer to 
participate in the study (n= 14), using insulin pen for less 
than 8 weeks (n= 8), and not being able to self-administer 
the insulin pen (n= 10). Consequently, 200 patients who 
met the research criteria and were willing to participate 
were enrolled in this study. 
Ethical considerations
Ethical approval, which agreed with the principles in the 
Declaration of  Helsinki (2013), was obtained by the local 
university institutional review board (Document Num-
ber: 50687469-1491-61-14/16484-99). Patient signed in-
formed consent before data collection. After data collec-
tion, the patients who were incorrectly implementing the 
steps of  insulin injection were trained by the researchers 
and steps were repeated on a mannequin until the errone-
ous implementation is corrected.
Measurement instruments
Socio-demographic and medical backgrounds of  patients 
were asked using the “socio-demographic and clinical 
characteristics form” and the insulin pen using tech-
niques steps were checked with the “insulin pen injection 
technique checklist”.
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Socio-demographic and clinical characteristics form
This form, comprise of  socio-demographic questions and 
data related to diabetes, was developed by the researchers 
in light of  medical literature12,19,20. The socio-demographic 
data comprised of  age, gender, marital status, educational 
status, employment status, exercise and smoking. Diabe-
tes-related data included; type, duration of  diabetes, dura-
tion of  insulin therapy, difficulty in injection, daily insulin 
injection times. Researchers also questioned presence of  
hypertension and dyslipidemia of  patients.
The HbA1c and other parameters were collected from the 
patients’ medical records that existed for last 3 months. 
The body mass index (BMI) was calculated based on 
height and weight [BMI=weight (kg)/ (height (m)2]23.
Injection sites on patient’s body were checked with ob-
servation and palpation for (1) lipodystrophy (lipohyper-
trophy, lipoatrophy), (2) bleeding and/or (3)bruise; the 
presence of  at least one of  them was accepted as a com-
plication10,15,24,25.  
Insulin pen injection technique checklist
This checklist comprises the rules or informations that 
related to insulin pen injection developed based on the 
disposable insulin pen manufacturer instructional guide-
lines and articles referencing insulin injection technique 
and storage10,26. The checklist comprises 19 items under 3 
main section (Table 2). The sections were: (1) Preparation 
and Knowledge about Insulin Pen, (2) Site of  Injection 
and Tissue, and (3) Using Devices and Injection Tech-
nique. Patients’ injection skills and their knowledge with 
regard to insulin injection were assessed with this form. 
Data collection procedure
In our department of  endocrinology and metabolism 
out-patient clinic, insulin pen prescribed patients with di-
abetes are called for routine control visit at regular inter-
vals by the physician, unless there is an emergency. When 
the patients with diabetes are prescribed insulin pen, they 
are trained on diabetes and insulin pen use by nurses. In 
the control visit, as a part of  our study, after obtaining 
the signed consent, patients were asked to show how they 
inject the insulin on a mannequin without the researcher 
nurse’s interference in the out-patient education room. 
Patients were observed during the insulin pen injection 
and their knowledge on the issue was assessed with ref-
erence to the Insulin pen injection technique checklist 
by the researchers. After injection practice on the mod-
el, patients’ body was examined to evaluate if  there were 
any injection complications in the injection sides on their 
body.  
During the observation, the researcher nurse was assess-
ing the patients’ knowledge about the number of  injec-
tions per day, needle length, the injection sites, whether 
the skin fold technique and rotation was being used, nee-
dle entry angle, the time the needle remains under skin, 
needle reuse, how to pull out the needle after injection, 
and the storage conditions. Each step of  insulin pen in-
jection was marked on the checklist as “correct” or “in-
correct” by research nurse. The questions that could not 
be presented by patients on a mannequin were verbally 
asked to patients. 
Data analysis
SPSS for Windows 15.0 (SPSS Inc., Chicago, IL., USA) 
package program was used for the data analysis. Data on 
descriptive statistics were presented in number, percent-
age and mean±standard deviation. “Correct/incorrect” 
steps on the insulin pen injection checklist and categorical 
variables were compared using a Chi-square test. p<0.05 
was accepted as statistically significant.
Results
The mean age of  the participant was 59.91 ± 11.29 (min: 
23-max: 86) years. More than half  of  participants were 
female (59.0%), 77.0% were married, and 63.6% were pri-
mary school graduate. The majority of  the participants 
(88.5%) had type 2 diabetes and mean duration of  di-
abetes was 12.77 ± 7.36 years. The Socio-demographic 
and clinical characteristics of  participants are presented 
in Table 1.  
African Health Sciences Vol 19 Issue 1, March, 20191630
With regard to the participants’ insulin pen injection 
techniques, the most correct steps or knowledge were 
keeping the insulin pen in the same angle during injection 
(99.5%), grasping the injection site in the right position 
while injecting (98.5%), keeping the spare cartridge or 
insulin pen in the refrigerator (97.0%), correctly setting 
the prescribed dosage (96.5%) and penetrating the skin 
with a right needle angle. Also the most incorrect steps or 
knowledge were using the insulin pen or the cartridge af-
ter the expiry date (79.5%), not rotating the injection site 
(70.5%), massaging the skin after injection (63.0%) and 
ejecting the excess air away before each injection (56.5%) 
(Table 2.). 
Table 1. Socio-demographic and clinical characteristics of patients (n = 200). 
 
Characteristics n (%) 
Age (years)  (mean ± SD) 59.91 ± 11.29 
Gender     
   Female 118 (59.0) 
   Male  82 (41.0) 
Marital status    
   Married 154 (77.0) 
   Single  46 (23.0) 
Educational status   
   Primary school or less 
   High School 




Employment status    
   Employed  24 (12.0) 
   Unemployed  94 (47.0) 
   Retired 82 (41.0) 
Smoking    
   Yes  17 (8.5) 
   No  183 (91.5) 
Hypertension     
   Yes 90 (40.0) 
   No 110 (60.0) 
Dyslipidemia    
   Yes 191 (95.5) 
   No  9 (4.5) 
Type of diabetes    
   Type 1 23 (11.5) 
   Type 2 177 (88.5) 
Disease duration (years) (mean ± SD) 12.77 ± 7.36 
Duration of insulin therapy (years) (mean ± SD) 7.56 ± 6.00 
Difficulty in injection   
   Yes  167 (83.5) 
   No  33 (16.5) 
HbA1c (%) (mean ± SD)   10.48 ± 1.78 
BMI (kg/m2) (mean ± SD) 31.86 ± 6.14 
Regular exercise    
   Yes 
   No 
76 (38.0) 
124 (62.0) 
Daily insulin injection   
   1-2 times 




Data have been presented as n (%) or mean ± standard deviation. HbA1C, Glycosylated hemoglobin A1C; BMI, Body mass index.  
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Preparation and Knowledge About Insulin Pen     
Q1. Disposing the insulin pen or cartridge after expiry date even if it is not empty. 41 (20.5) 159 (79.5) 
Q2. Knowing the length of the needle. 79 (39.5) 121 (60.5) 
Q3. Keeping the insulin pen and the spare cartridge in the right storage bag when 
travelling.  165 (82.5) 35 (17.5) 
Q4. Keeping the insulin in the right storage conditions currently. 165 (82.5) 35 (17.5) 
Q5. Keeping the insulin in the refrigerator at 2-8 ºC when room temperature is 
over 28 ºC (in summer). 167 (83.5) 33 (16.5) 
Q6. Keeping the spare cartridge or insulin pen in the refrigerator. 194 (97.0) 6 (3.0) 
Site of Injection and Tissue      
Q7. Knowing the body injection sites. 142 (71.0) 58 (29.0) 
Q8. Rotating the injection sites. 59 (29.5) 141 (70.5) 
Q9. Grasping the injection site in the right position when injecting.  197 (98.5) 3 (1.3) 
Q10. Not massaging the skin after injection. 74 (37.0) 126 (63.0) 
Using Devices and Injection Technique      
Q11. Able to change the cartridge when required. 185 (92.5) 15 (7.5) 
Q12. Using a new needle for each injection. 98 (49.0) 102 (51.0) 
Q13. Ejecting the excess air away before each injection. 87 (43.5) 113 (56.5) 
Q14. Ejecting the excess air in the injector correctly. 91 (45.5) 109 (54.5) 
Q15. Correctly setting the prescribed dosage. 193 (96.5) 7 (3.5) 
Q16. Penetrating the skin with a right needle angle, and keeping it in the same 
angle during injection. 199 (99.5) 1 (0.5) 
Q17. After penetrating the skin, pushing the injector piston correctly. 198 (99.0) 2 (1.0) 
Q18. After injection, counting to ten before removing the needle. 115 (57.5) 85 (42.5) 
Q19. Removing the needle with same penetration angle. 196 (98.0) 4 (2.0) 
“Q” Question. 
It was found that complications related to insulin injec-
tion were statistically more significant in participants who 
were using the insulin pen or the cartridge after the expiry 
date (x2 = 4.500; p = 0.034), who did not know the prop-
er length of  the needle (x2 = 10.880; p = 0.001) and the 
possible body injection sites (x2 = 3.310; p = 0.049), who 
didnot rotate the injection sites (x2= 7.698; p = 0.006), 
who massaged the skin after injection (x2= 6.056; p= 
0.013), and who did not use a new needle at each injection 
(x2 = 10.305; p = 0.001) (Table 3).
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Table 3. Comparison of insulin pen using skills (correct/incorrect) and complications on the 
injection site (n=200) 
Insulin Pen Using Skills 
Questions 
Correct Incorrect 
x2 p Complication Complication 
Yes No  Yes No  
n (%) n (%) n (%) n (%) 
Preparation and Knowledge About Insulin Pen     
Q1. Disposing the insulin pen or cartridge after expiry 














(90.9) 11 (9.1) 10.880 
0.001* 
Q3. Keeping the insulin pen and the spare cartridge in 






(85.7) 5 (17.5) 0.093 
0.761 







(91.4) 3 (8.6) 1.742 
0.187 
Q5. Keeping the insulin in the refrigerator at 2-8 ºC 






(87.9) 4 (12.1) 0.442 0.506 







(83.3) 1 (16.7) 0.002 
0.964 
Site of Injection and Tissue   




(91.4) 5 (9.6) 3.310 
0.049* 






Q9. Grasping the injection site in the right position 






(100.0) - 0.580 
 0.446 








Using Devices and Injection Technique   




(93.3) 1 (6.7) 1.051 
0.305 




(92.2) 8 (7.8) 10.305 
0.001* 























(85.7) 1 (14.3) 0.016 
0.900 
Q16. Penetrating the skin with a right needle angle, 






(100.0) - 0.191 0.662 







(100.0) - 0.385 
0.535 







(88.2) 10(11.8) 1.973 
0.160 







(75.0) 1(25.0) 0.246 
0.620 
(*), p < 0.05 statically significant. x2, Pearson Chi- Square Test or Fisher Exact Test for some cells have expected 
count less than 5 
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In addition, frequency of  having complications related 
to insulin injection on the injection side was statistically 
significantly higher in participants who were unemployed 
(p= 0.023), low educational status (p = 0.034), long-term 
insulin user (p = 0.015), experiencing difficulties in injec-
tion (p = 0.001), not exercising regularly (p = 0.007), and 
having more than two daily injections (p = 0.028) (not 
shown in the table). 
Discussion
This is one of  the limited studies that have evaluated the 
insulin pen injection knowledge and skills of  patients 
with diabetes. The results of  this study showed that the 
majority of  the patients with diabetes were keeping the 
spare cartridge or insulin pen in the refrigerator, grasping 
the injection site in the right position while injecting, cor-
rectly setting the prescribed dosage and penetrating the 
skin with a right needle angle, and keeping it in the same 
angle during injection. On the other hand, the majority of  
the patients were not disposing the insulin pen after the 
expiry date, not rotating the injection sites or massaging 
the skin after injection, not using a new needle for each 
injection. 
Subcutaneous tissue is preferred for insulin injection 
because of  the predictable absorption rate that allows a 
better glycemic control14,18,26. A less deep injection in the 
intradermal tissue may result in absorption at unpredict-
able rates, leakage and allergic reactions. Also because of  
the rich blood flow to the muscle, the risk of  the insulin 
to be absorbed faster increases in intramuscular injection, 
which may lead to hypoglycemia and glycemic variations. 
Moreover, intramuscular injections are more painful and 
may result in bruises14. These reasons require patients to 
know the length of  the needle, properly grasp the injec-
tion site, and inject in the correct location. However, in 
this study population, 60.5% did not know the length 
of  the needle and most of  them had complications. Pa-
tients using short needles such as 4 mm, 5 mm and 6 
mm should not lift the skin and inject at a 900 angle14,18. 
Moreover, massaging the skin after insulin injection may 
result in increased blood circulation on the injection site 
leading insulin to be absorbed very fast,10,21  increased tis-
sue damage on the skin and in subcutaneous layer due to 
injection trauma, subcutaneous bleeding and bruising24, 27. 
Likewise, in this study it was found that the complication 
frequency was more in patients massaging after insulin 
injection. 
One of  the key points to be focused on is using a new 
needle for each injection. If  the needle is not removed 
from the pen between two injections, air may leak into 
the injector causing wrong dose insulin injection. The in-
jection should be given directly to the skin, because the 
needle can be blunt when administered through clothing 
and increase the risk of  bleeding, bruising and infection14, 
17,20. Reusing the needle may result in distortion, bending 
and loss of  lubrication. This can lacerate the skin28 and 
cause painful injections29. Ji and Lou12 reported that pen 
needle reuse was quite high in their study and this find-
ing increased the risk of  lipohypertrophy.  Böhler et al.30 
found that only 40% of  their study population was using 
a new needle for each injection. Likewise, Mitchell et al.16 
reported that one fifth of  their population was keeping 
the needle attached on the pen, and 80% of  them were 
removing the needle from the pen after at least three in-
jections. Only half  of  the patients in this study were us-
ing a new needle for each injection. This number is very 
disappointing and requires special attention at patient ed-
ucation.
The correct rotation of  injection sites is the strongest 
protective factor against the development of  lipohyper-
trophy;10,12 Most of  the participants in this study (70.5%) 
were not rotating the injection site moreover one of  the 
complications such as lipodystrophy, bleeding and bruis-
ing was observed in patients who were not rotating regu-
larly and massaging after injection. Similar to our results, 
several studies reported that high rate of  not rotating the 
injection side and not controlling the skin for complica-
tions in patient with diabetes. In addition, all these stud-
ies reported that lipodystrophy occurred more frequent 
in patients with diabetes who did not rotate injection 
sites31,32. 
The results of  this study showed that frequency of  hav-
ing complications related to insulin injection was statisti-
cally significantly higher in participants who were long-
term insulin user, experiencing difficulties in injection, 
having more than two daily injections. Our findings sug-
gest that as long as the duration of  insulin treatment and 
the numbers of  daily injections increase, poorer injection 
techniques are adopted.Poor injection technique causes 
complications and unsatisfactory glycemic control11,22. 
Patients may have forgotten the correct injection tech-
nique or neglected some of  the steps over time. There-
fore, not only the initial patient education on insulin pen 
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use given by healthcare professionals is important, but 
also repetitive controls are important for a successful 
treatment protocol19.  One of  the major benefits of  this 
study is having the opportunity to determine the errone-
ous steps of  insulin injection and difficulties experienced 
by patients. This may shape the patient education and fol-
low-up visits by focusing on the erroneous steps. 
In the light of  our findings, nurses should be focused on 
common erroneous topics when caring for patients who 
use insulin pen injector. We suggest that knowing which 
steps bear a difficulty for patients and nurses, in which 
errors are common, may help focusing and adjusting the 
education program and therefore improving the effec-
tiveness and quality of  education. Diabetes nurses should 
inform the patients and explain the effects of  massag-
ing the skin after insulin injection and keep patients away 
from massaging. Patients should be educated on how to 
make rotation, the importance of  rotation and not us-
ing the area that lipohypertrophy occurred until the tissue 
gets normal, and they should be examined during each 
visit. Furthermore, they should be equipped with knowl-
edge and skills to self-examine the injection sites on their 
body by inspection and palpation.
Limitations 
This study was conducted on patients with diabetes in 
a tertiary training and research hospital. Therefore, our 
results may not be generalized to patients who are admit-
ted to and may not have sufficient support and service at 
primary or secondary health care facilities. In addition, it 
should be stated that the patients knew that they were be-
ing observed so they may have done some steps correctly.
 
Conclusion
It is important to train the patients who start insulin injec-
tion therapy on injection techniques and control the steps 
of  administration on follow-up visits. Healthcare profes-
sionals have the responsibility to equip the patients with 
adequate knowledge, skills and competence. The insulin 
injection skills of  patients with diabetes were poor, and 
the incidence of  complications was high in this study. As 
the duration of  insulin therapy gets longer and the num-
bers of  daily injections increase, incidence of  complica-
tions on the injection site increases. Improved education 
in optimal insulin injection technique, especially focused 
on reducing needle reuse, correct rotation of  injection 
sites and not massaging the skin after injection, should be 
emphasized. 
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